Abstract | BACKGROUND: METHODS: Renal artery clamping was used to establish IR-AKI and post-injury fibrosis model. HE and Masson staining were performed to observe renal fibrosis. The protein abundance levels were measured along with inflammatory markers, renal complement C3. Podocytes were treated with C3a with or without Toll-like receptor 4(TLR4) inhibitor. The effects of TLR4 up-regulation by TLR4 plasmids were examined. RESULTS: C3-/- resulted in amelioration of renal dysfunction by reducing podocyte damage and renal fibrosis. Immunoblot with renal tissue homogenates from IR-AKI mice revealed that C3-/- decreased TLR4/Nuclear Factor-κB (NFκB)-P65. CONCLUSION: Our results indicate that modulating C3/TLR4/NFκB-P65 signaling pathway is a novel therapeutic target for the IR-AKI and post-injury fibrosis.
|
Authors | Yi Chen, Liyu Lin, Siyi Rao, Xuan Tao, Jiong Cui, Jianxin Wan |
Journal | European journal of medical research
(Eur J Med Res)
Vol. 28
Issue 1
Pg. 135
(Mar 27 2023)
ISSN: 2047-783X [Electronic] England |
PMID | 36973754
(Publication Type: Journal Article)
|
Copyright | © 2023. The Author(s). |
Chemical References |
- Complement C3
- Toll-Like Receptor 4
- NF-kappa B
- Tlr4 protein, mouse
|
Topics |
- Mice
- Animals
- Podocytes
(metabolism, pathology)
- Complement C3
(genetics, metabolism)
- Toll-Like Receptor 4
(genetics, metabolism, therapeutic use)
- Kidney
(pathology)
- Acute Kidney Injury
(genetics, metabolism)
- Signal Transduction
- NF-kappa B
(genetics, metabolism)
- Reperfusion Injury
(drug therapy)
- Ischemia
(metabolism, pathology)
- Reperfusion
- Fibrosis
|